Enterohepatic bile salt transporters in normal physiology and liver disease.

By G. Kullak-Ublick, B. Stieger, P. Meier. Gastroenterology, 2004

647 citations recorded by the source corpus.

Subfields: Nutrition and Dietetics, Oncology, Surgery

View Paper: https://www.semanticscholar.org/paper/cba4f889ca467ca4b2fb6b8f01d9e6936fdee37a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. Bart Staels

Citations in the corpus

• Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME (2013, neutral): “…acids, conjugated and unconjugated bilirubin, thyroid hormones and leucotriene C4 as well as drugs such as pravastatin, rifampicin, metotrexate, benzylpenicillin and fexofenadine (Cvetkovic et al. 1999; Nishizato et al. 2003; Kullak-Ublick et al. 2004; Konig et al. 2006; van de Steeg et al. 2009).”
• Role of bile acids and bile acid receptors in metabolic regulation. (2009, background): “In addition, defects in transporter systems related to human cholestatic liver diseases have been subject of several, well-referenced reviews (76, 163, 235).”